3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Completed
1
Sponsor
Conditions
Neoplasms
1
Neoplasm Metastasis
1
Hemorrhage
1
Diarrhea
1
Colitis
1
Interventions
Cyclophosphamide
16
fludarabine
12
Rituximab
4
Antigens, CD19
4
Lenalidomide
3
Immunotherapy, Adoptive
3
Etoposide
3
orelabrutinib
2
Nivolumab
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Methotrexate
2
zanubrutinib
1
relmacabtagene autoleucel
1
prednylidene
1
obinutuzumab
1
merphos
1
ixazomib
1
gemcitabine-oxaliplatin regimen
1
fludarabine phosphate
1
entecavir
1
eltrombopag
1
deltacortene
1
abivertinib
1
Vincristine
1
Transplantation, Autologous
1
Tenofovir
1
Prednisone
1
Pentostatin
1
Melphalan
1
Interleukin-7
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, B-Cell
×
Cell- and Tissue-Based Therapy
×
Clear all
No trials found.